Fate of mitral regurgitation after transcatheter closure of patent ductus arteriosus: single centre study

A hemodynamically significant patent ductus arteriosus (PDA) may be associated with mitral regurgitation (MR). Available treatment strategies are - surgical PDA ligation ± mitral valve surgery and initial transcatheter PDA closure (PDA-DC) with treatment of MR subsequently, if necessary. We aimed to...

Full description

Saved in:
Bibliographic Details
Main Authors: Gayathri Bhuvaneswaran Kartha, Shruti Irene Varghese, Jesu Krupa, Anoop George Alex, Oommen K. George, Viji Samuel Thomson
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Indian Heart Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483225000641
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A hemodynamically significant patent ductus arteriosus (PDA) may be associated with mitral regurgitation (MR). Available treatment strategies are - surgical PDA ligation ± mitral valve surgery and initial transcatheter PDA closure (PDA-DC) with treatment of MR subsequently, if necessary. We aimed to describe the fate of MR after PDA-DC in patients with PDA and significant MR. On retrospective review of electronic health records between 2013 and 2023, 14 eligible patients were identified. Amongst them, PDA-DC resulted in symptomatic improvement in all. A reduction in the severity of MR was noted in 12 patients (85.7 %).
ISSN:0019-4832